JP2004524292A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004524292A5 JP2004524292A5 JP2002556156A JP2002556156A JP2004524292A5 JP 2004524292 A5 JP2004524292 A5 JP 2004524292A5 JP 2002556156 A JP2002556156 A JP 2002556156A JP 2002556156 A JP2002556156 A JP 2002556156A JP 2004524292 A5 JP2004524292 A5 JP 2004524292A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- pharmaceutical formulation
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01500007 | 2001-01-11 | ||
| EP01500206 | 2001-08-02 | ||
| US32978601P | 2001-10-16 | 2001-10-16 | |
| EP01500263A EP1310480A1 (en) | 2001-11-07 | 2001-11-07 | Prodrugs of excitatory amino acids |
| PCT/US2001/045866 WO2002055481A1 (en) | 2001-01-11 | 2001-12-21 | Prodrugs of excitatory amino acids |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004524292A JP2004524292A (ja) | 2004-08-12 |
| JP2004524292A5 true JP2004524292A5 (https=) | 2006-08-17 |
| JP4064237B2 JP4064237B2 (ja) | 2008-03-19 |
Family
ID=27440162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002556156A Expired - Fee Related JP4064237B2 (ja) | 2001-01-11 | 2001-12-21 | 興奮性アミノ酸のプロドラッグ |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US7256217B2 (https=) |
| EP (1) | EP1368304B1 (https=) |
| JP (1) | JP4064237B2 (https=) |
| KR (1) | KR20030090622A (https=) |
| CN (1) | CN1267407C (https=) |
| AR (1) | AR036007A1 (https=) |
| AT (1) | ATE356111T1 (https=) |
| AU (1) | AU2002228737B2 (https=) |
| BR (1) | BR0116770A (https=) |
| CA (1) | CA2433667C (https=) |
| CZ (1) | CZ303490B6 (https=) |
| DE (1) | DE60127182T2 (https=) |
| DZ (1) | DZ3461A1 (https=) |
| ES (1) | ES2282315T3 (https=) |
| HU (1) | HUP0400620A3 (https=) |
| IL (1) | IL156364A0 (https=) |
| MX (1) | MXPA03006186A (https=) |
| NO (1) | NO20033166L (https=) |
| NZ (1) | NZ526050A (https=) |
| PE (1) | PE20020829A1 (https=) |
| PL (1) | PL208413B1 (https=) |
| SK (1) | SK287934B6 (https=) |
| SV (1) | SV2003000836A (https=) |
| WO (1) | WO2002055481A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20080058509A (ko) | 2002-06-11 | 2008-06-25 | 일라이 릴리 앤드 캄파니 | 흥분성 아미노산의 전구약물 |
| WO2010111080A2 (en) | 2009-03-27 | 2010-09-30 | Eli Lilly And Company | Optimized treatment of schizophrenia |
| AR079343A1 (es) * | 2009-12-21 | 2012-01-18 | Lilly Co Eli | Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico |
| DK2721012T3 (en) | 2011-06-17 | 2016-08-15 | Lilly Co Eli | Biclo (3.1.0) hexane-2,6-dicarboxylic acid derivatives as MGLU2 receptor agonist |
| AR089718A1 (es) | 2012-02-01 | 2014-09-10 | Lilly Co Eli | AGONISTAS DE mGlu2/3 |
| CN112041310B (zh) * | 2018-04-17 | 2023-11-03 | 拜耳公司 | 制备包含具有酸-不稳定性的酮保护基的n-酰化氨基酸酯的方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5750566A (en) * | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
| PL182285B1 (pl) | 1994-08-12 | 2001-12-31 | Lilly Co Eli | Syntetyczne aminokwasy oraz ich estry i srodki farmaceutyczne je zawierajace PL PL PL PL PL PL PL |
| ATE206915T1 (de) | 1994-08-12 | 2001-11-15 | Lilly Co Eli | Behandlung von angstzuständen |
| IL118727A (en) | 1995-06-29 | 2003-01-12 | Lilly Co Eli | (-)-2-spiro-5-hydantoinbicyclo [3.1.0] hexane-6-carboxylic acid, salts thereof and use thereof for the preparation of (+)-(2) aminobicyclo [3.1.0] hexane-2,6-dicarboxylic acid |
| ZA983930B (en) * | 1997-05-14 | 1999-11-08 | Lilly Co Eli | Excitatory amino acid receptor modulators. |
| DE69906492T2 (de) | 1998-01-28 | 2003-12-18 | Taisho Pharmaceutical Co., Ltd. | Fluorhaltige aminosäurederivate |
| GB9815542D0 (en) | 1998-07-17 | 1998-09-16 | Lilly Co Eli | Bicyclohexane derivatives |
| US6528499B1 (en) | 2000-04-27 | 2003-03-04 | Georgetown University | Ligands for metabotropic glutamate receptors and inhibitors of NAALADase |
| US7038077B2 (en) | 2001-01-11 | 2006-05-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| EP1423411A2 (en) | 2001-07-09 | 2004-06-02 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| EP1463713A1 (en) | 2001-11-23 | 2004-10-06 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
| WO2003057661A1 (en) | 2001-12-21 | 2003-07-17 | Eli Lilly And Company | Prodrugs of excitatory amino acids |
-
2001
- 2001-12-14 HU HU0400620A patent/HUP0400620A3/hu unknown
- 2001-12-14 CN CNB018219667A patent/CN1267407C/zh not_active Expired - Fee Related
- 2001-12-14 NZ NZ526050A patent/NZ526050A/en unknown
- 2001-12-14 US US10/250,448 patent/US7256217B2/en not_active Expired - Fee Related
- 2001-12-14 IL IL15636401A patent/IL156364A0/xx unknown
- 2001-12-21 BR BR0116770-7A patent/BR0116770A/pt not_active IP Right Cessation
- 2001-12-21 SK SK826-2003A patent/SK287934B6/sk not_active IP Right Cessation
- 2001-12-21 AT AT01989859T patent/ATE356111T1/de not_active IP Right Cessation
- 2001-12-21 CA CA2433667A patent/CA2433667C/en not_active Expired - Fee Related
- 2001-12-21 KR KR10-2003-7009216A patent/KR20030090622A/ko not_active Withdrawn
- 2001-12-21 EP EP01989859A patent/EP1368304B1/en not_active Expired - Lifetime
- 2001-12-21 PL PL361669A patent/PL208413B1/pl unknown
- 2001-12-21 DZ DZ013461A patent/DZ3461A1/fr active
- 2001-12-21 DE DE60127182T patent/DE60127182T2/de not_active Expired - Lifetime
- 2001-12-21 JP JP2002556156A patent/JP4064237B2/ja not_active Expired - Fee Related
- 2001-12-21 AU AU2002228737A patent/AU2002228737B2/en not_active Ceased
- 2001-12-21 WO PCT/US2001/045866 patent/WO2002055481A1/en not_active Ceased
- 2001-12-21 ES ES01989859T patent/ES2282315T3/es not_active Expired - Lifetime
- 2001-12-21 CZ CZ20031916A patent/CZ303490B6/cs not_active IP Right Cessation
- 2001-12-21 MX MXPA03006186A patent/MXPA03006186A/es active IP Right Grant
-
2002
- 2002-01-10 PE PE2002000010A patent/PE20020829A1/es not_active Application Discontinuation
- 2002-01-11 SV SV2002000836A patent/SV2003000836A/es not_active Application Discontinuation
- 2002-01-11 AR ARP020100085A patent/AR036007A1/es unknown
-
2003
- 2003-07-10 NO NO20033166A patent/NO20033166L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW505623B (en) | Excitatory amino acid receptor modulators | |
| CN104136416B (zh) | 苯基烷基氨基甲酸酯衍生物化合物以及包含该苯基烷基氨基甲酸酯衍生物化合物的药物组合物 | |
| JP2006503807A5 (https=) | ||
| CA2318800A1 (en) | Fluorine-containing amino acid derivatives | |
| JP7036792B2 (ja) | スピロ－ラクタムｎｍｄａ受容体修飾因子およびその使用 | |
| HK1052506A1 (zh) | 化合物 | |
| CA2438991A1 (en) | Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists | |
| US9464066B2 (en) | Deuterated compounds useful for treating neurodegenerative diseases | |
| EP1256576A1 (en) | Fused imidazolium derivatives | |
| EA016687B8 (ru) | Производные циклопропиламида | |
| US20230416219A1 (en) | R-mdma crystal forms | |
| MXPA05000435A (es) | Derivados de azabiciclo como antagonistas de receptor muscarinico. | |
| JP2002511835A (ja) | 神経障害および神経病の治療に有用な受容体作動性カルシウムチャネル上の新規部位で活性な化合物 | |
| AU2001281861B2 (en) | 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinicreceptor antagonists | |
| JP2004524292A5 (https=) | ||
| JP2024540030A (ja) | 修飾インドール化合物 | |
| US6448282B1 (en) | 1H-4(5)-substituted imidazole derivatives | |
| KR20050065646A (ko) | 칼슘 채널 알파-2-델타 서브유닛에 대한 친화성을 갖는프롤린 유도체 | |
| JP2009502941A (ja) | ニューロパシーおよび関連障害の治療のための方法および組成物 | |
| CA2433667A1 (en) | Prodrugs of excitatory amino acids | |
| US6500866B1 (en) | 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission | |
| JP6936257B2 (ja) | Ｅａａｔ３阻害剤としてのピラゾール化合物 | |
| CN112225673B (zh) | 氨基康普立停衍生物及其应用 | |
| CN103570669B (zh) | 脑靶向o-去甲基文拉法辛酚酯类前药及制备方法和用途 | |
| EP0840731B1 (en) | Polycyclic alcaloid-derivatives as nmda-receptor antagonists |